A first encounter with the dengue virus typically causes very mild symptoms; however, a subsequent infection is a different story. For a small proportion of people who are reinfected, the virus can ...

The antibody's altered structure helps explain an enduring mystery of dengue -- why only a fraction of those infected will develop severe disease. A first encounter with the dengue virus typically ...

Explore how innovative antibody quantification technologies improve data quality, reproducibility, and decision-making in ...

The global monoclonal antibody for asthma and COPD market size was valued at USD 34.02 billion in 2025 and is predicted to ...

Creative Biolabs offers comprehensive small-molecule antibody services and assists every detail from hapten design to antibody production. New York, USA – July 7, 2022 – Small molecules are common ...

J&J is also running mid-stage trials of a tau active immunotherapy codenamed JNJ-2056 for Alzheimer's, while other active tau ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

A new cancer treatment available at the Mercy Health — Paducah Cancer Center offers a “cutting edge” form of immunotherapy ...

BOSTON, May 30, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa), a clinical-stage biotechnology company developing novel biologics for inflammatory and immunological diseases, today ...